Evaluating Compassion Focused Therapy to Reduce Internalized Stigma in Mental Disorders A Multi-center Randomized Controlled Study
Led by University Hospital, Strasbourg, France · Updated on 2026-08-19
336
Participants Needed
7
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
People with mental disorders often experience stigma from others and may internalize these negative attitudes, leading to self-stigma. This self-stigma can cause emotional distress such as shame and reduce coping skills, making social interaction and adherence to care more difficult. The study aims to evaluate the effectiveness and acceptability of group-based Compassion Focused Therapy CFT in reducing self-stigma, compared to treatment as usual and a psychoeducation program previously studied.
The study compares three approaches Compassion Focused Therapy, which includes both psychoeducation and experiential exercises to foster self-compassion and reduce shame a psychoeducation program called Ending Self Stigma that helps participants modify self-stigmatizing thoughts and increase self-esteem and treatment as usual. The interventions involve sessions with practices such as guided imagery and writing exercises, with some activities provided online for home practice.
Participants will be adults with chronic psychiatric or neurodevelopmental disorders who have moderate to high self-stigma. They will be assessed using the Internalized Stigma of Mental Illness inventory at baseline and monthly for three months. The study will monitor changes in self-stigma and other clinical aspects over the treatment period. Participation involves random assignment to one of the study groups, and safety and acceptability will be evaluated throughout the study, which is expected to run until 2028.
CONDITIONS
Brief Title
COMpassion for Psychiatric Disorders And Self-Stigma
Research Team
L
Luisa Weiner
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patient informed of the results of the preliminary medical examination
Patient affiliated to a social health insurance plan (beneficiary or family member)
Diagnosis of one or more chronic psychiatric disorders (schizophrenia, schizoaffective disorder, bipolar disorder, recurrent major depression, borderline personality disorder) or neurodevelopmental disorder (autism spectrum disorder)
Treated as an outpatient or in a day hospital
Clinical Global Impression-Severity score less than 6 assessed by psychiatrist
Internalized Stigma of Mental Illness inventory score indicating moderate to high self-stigma (greater than 2.5)
You will not qualify if you...
Currently in an exclusion period due to participation in another study
Participating in an interventional study involving psychotherapy or experimental drugs
Experiencing an acute episode of their disorder based on Clinical Global Impression-Severity score
In a medical emergency or life-threatening situation
Intellectual disability with IQ less than 70
Under legal care constraints or deprived of freedom by judicial measure
Insufficient French language skills to participate
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Similar Trials
Long-Term Safety and Tolerability Study of LB-102 in Adults With Stable Schizophrenia Over 52 Weeks
Effects of a Single Dose of Citalopram on Brain Activity in Emotional Processing Using 7T fMRI
Imaging PDE4B in Major Depressive Disorder Using PET with 18FPF-06445974 and Apremilast Assessment
20-Year Follow-up Study on Early Treatment and Relapse Effects in First Episode Psychosis
Study Comparing Two Formulations of Paliperidone Palmitate Injection 3M in Chinese Adults with Schizophrenia
Randomized, Open-label, Multicenter, Multiple-dose Bioequivalence Study
Early Intervention Program for Preschool Children With Developmental Disorders Including Autism Spectrum Disorder
Chatbot Program to Improve Well-being in Caregivers of Children Ages 6 to 11 with Autism Spectrum Disorder
A Phase 2 Study to Assess Safety and Effectiveness of Different Olanzapine Dosing Schedules in Adults with Schizophrenia
Building a Prediction Model for Bipolar Disorder in High-Risk Youth Using Multimodal Data
A Multicenter, Large Sample, Prospective Cohort Study
Comparing Two School Programs to Reduce Anxiety and Improve Emotion Regulation in Autistic Students Ages 8 to 14
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Compassion-focused therapy (CFT) for the reduction of the self-stigma of mental disorders: the COMpassion for Psychiatric disorders, Autism and Self-Stigma (COMPASS) study protocol for a randomized controlled study.